Literature DB >> 11982584

Takes your breath away--the immunology of allergic alveolitis.

C McSharry1, K Anderson, S J Bourke, G Boyd.   

Abstract

Extrinsic allergic alveolitis (synonym: hypersensitivity pneumonitis) is caused by inhaling antigenic aerosols which induce hypersensitivity responses in susceptible individuals. It is an interstitial inflammatory disease affecting the distal, gas-exchanging parts of the lung, in contrast to allergic asthma where the inflammation is more proximal, affecting the conducting airways. The aims of this review are to describe current concepts of the immunology of this model of lung inflammation, to describe some of the constitutional and environmental characteristics which affect disease susceptibility and development, and to describe topics for prospective study.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11982584      PMCID： PMC1906376          DOI： 10.1046/j.1365-2249.2002.01849.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  73 in total

1.  Pigeon fancier's lung.

Authors:  S Bourke; G Boyd
Journal:  BMJ       Date:  1997-07-12

2.  Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey.

Authors:  Y Yoshizawa; Y Ohtani; H Hayakawa; A Sato; M Suga; M Ando
Journal:  J Allergy Clin Immunol       Date:  1999-02       Impact factor: 10.793

3.  Pigeon fancier's lung. Current methodology is not sensitive enough to monitor effectiveness of avoidance measures.

Authors:  A M Ward; P A White
Journal:  BMJ       Date:  1997-11-15

Review 4.  Mechanisms accounting for granulomatous responses in hypersensitivity pneumonitis.

Authors:  M Suga; H Yamasaki; K Nakagawa; H Kohrogi; M Ando
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1997-09       Impact factor: 0.670

5.  Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage (BAL) fluids of extrinsic allergic alveolitis.

Authors:  N Shijubo; K Imai; K Shigehara; M Hirasawa; M Tsujisaki; Y Hinoda; S Abe
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

6.  Potentially fatal hypersensitivity pneumonitis in a child.

Authors:  J Krasnick; R Patterson; P C Stillwell; M G Basaran; L H Walker; R Kishore
Journal:  Clin Pediatr (Phila)       Date:  1995-07       Impact factor: 1.168

7.  Tumor necrosis factor-alpha -308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients.

Authors:  B M Schaaf; U Seitzer; V Pravica; S P Aries; P Zabel
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

8.  Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice.

Authors:  G Gudmundsson; A Bosch; B L Davidson; D J Berg; G W Hunninghake
Journal:  Am J Respir Cell Mol Biol       Date:  1998-11       Impact factor: 6.914

9.  Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis.

Authors:  Y Sugiyama; T Kasahara; N Mukaida; K Matsushima; S Kitamura
Journal:  Eur Respir J       Date:  1995-07       Impact factor: 16.671

10.  IL-12 modulates expression of hypersensitivity pneumonitis.

Authors:  G Gudmundsson; M M Monick; G W Hunninghake
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422
View more
  8 in total

1.  Utility of precipitating antibody testing in the diagnostic evaluation of chronic hypersensitivity pneumonia.

Authors:  Federica De Giacomi; Anita Andreano; Paola Faverio; Alice Biffi; Leonardo Ruvolo; Nicola Sverzellati; Maria Grazia Valsecchi; Alberto Pesci
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 2.  Where asthma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma.

Authors:  Pieter Bogaert; Kurt G Tournoy; Thomas Naessens; Johan Grooten
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

Review 3.  Allergy and the lung.

Authors:  G Passalacqua; G Ciprandi
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

Review 4.  Innate immunity and the pathogenicity of inhaled microbial particles.

Authors:  C Henrik J Wolff
Journal:  Int J Biol Sci       Date:  2011-03-15       Impact factor: 6.580

5.  Draft Genome Sequence of Saccharopolyspora rectivirgula.

Authors:  B M Fredrik Pettersson; P R Krishna Behra; Satyam Manduva; Sarbashis Das; Santanu Dasgupta; Alok Bhattacharya; Leif A Kirsebom
Journal:  Genome Announc       Date:  2014-01-09

6.  Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis.

Authors:  Stijn Willems; Willems Stijn; Stijn E Verleden; Bart M Vanaudenaerde; Marijke Wynants; Wynants Marijke; Christophe Dooms; Dooms Christophe; Jonas Yserbyt; Yserbyt Jonas; Jana Somers; Somers Jana; Eric K Verbeken; Geert M Verleden; Wim A Wuyts
Journal:  Ann Thorac Med       Date:  2013-01       Impact factor: 2.219

7.  Proteomic changes of alveolar lining fluid in illnesses associated with exposure to inhaled non-infectious microbial particles.

Authors:  Laura Teirilä; Kirsi Karvala; Niina Ahonen; Henrik Riska; Anne Pietinalho; Päivi Tuominen; Päivi Piirilä; Anne Puustinen; Henrik Wolff
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

8.  Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.

Authors:  Devalingam Mahalingam; Manish R Patel; Jasgit C Sachdev; Lowell L Hart; Niels Halama; Ramesh K Ramanathan; John Sarantopoulos; Dirk Völkel; Ashraf Youssef; Floris A de Jong; Apostolia Maria Tsimberidou
Journal:  Br J Clin Pharmacol       Date:  2020-04-12       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.